Concepedia

Author

Joel Neutel

Orange County Research Center

Also Known As

David Mishkin, David Morin, J Neutel, J. W. Neutel, JOEL NEUTEL, Joel Neutel

81

Publications

2.8K

Citations

24

H-Index

51

Concepts

All Affiliations

Orange County Research CenterAmgen (United States)The University of Western AustraliaCentre hospitalier de l'Université LavalBaylor College of Medicine
JN

About

Joel Neutel is an author at Orange County Research Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

845

2

Health Sciences

3

3

206

3

Public Health

1

1

30

4

Applied Physiology

1

1

106

5

Biomolecular Engineering

1

1

218

Joel Neutel

×

31

Publications

2.5K

Citations

22

H-Index

YearCitations

Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension

Gary F. Mitchell, Yves Lacourcière, Jean-Pascal Ouellet,

Circulation

2003

321

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

Suzanne Oparil, Steven G. Chrysant, Thomas Marbury,

Journal of Clinical Hypertension

2001

263

Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension

Gary F. Mitchell, Joseph L. Izzo, Yves Lacourcière,

Circulation

2002

223

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

Michael J. Koren, Patrick M. Moriarty, Seth J. Baum,

Nature Medicine

2022

218

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber,

The Lancet

2022

206

Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension

Gary F. Mitchell, Paul R. Conlin, Mark E. Dunlap,

Hypertension

2007

179

Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia

Christie M. Ballantyne, Joel Neutel, Anne Cropp,

The American Journal of Cardiology

2015

168

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan,

Nature Metabolism

2024

160

Ventilatory mechanisms of exercise intolerance in chronic heart failure

Jonathan Myers, Azar Salleh, Nancy Buchanan,

American Heart Journal

1992

106

Individualized ramp treadmill. Observations on a new protocol.

Jonathan Myers, Nancy Buchanan, David L. Smith,

PubMed

1992

98

Page 1